Ostertagiosis in Cattle: Diagnostic Approaches and Anthelmintic Resistance Monitoring

Abstract

Ostertagiosis, caused by the abomasal nematode Ostertagia ostertagi, represents a major production-limiting parasitic disease of cattle globally. This review synthesizes current diagnostic paradigms encompassing coprological quantification, immunodiagnostic assays, and post-mortem lesion scoring. Particular emphasis is placed on the fecal egg count reduction test (FECRT) as the gold standard for anthelmintic efficacy assessment, enzyme-linked immunosorbent assay (ELISA) platforms for herd-level exposure profiling, and the integration of these tools within targeted selective treatment (TST) frameworks. Advances in understanding parasite excretory-secretory products, host immune modulation, and the pathophysiology of type I and type II ostertagiosis inform the interpretation of diagnostic outputs. Computational approaches to resistance allele frequency modeling and decision-support algorithms for sustainable parasite control are discussed.

1. Introduction and Pathobiology

Ostertagia ostertagi, the brown stomach worm, is a trichostrongylid nematode inhabiting the abomasum of cattle. The parasite exhibits a direct life cycle with free-living stages (eggs, first-stage larvae L1, second-stage larvae L2, infective third-stage larvae L3) and parasitic stages (L3, fourth-stage larvae L4, adults). Infection dynamics are governed by seasonal pasture contamination, host immunity, and the phenomenon of hypobiosis (arrested development) at the early L4 stage within the gastric glands [13].

1.1 Pathophysiological Mechanisms

The pathogenesis of ostertagiosis involves both worm-mediated and host-mediated components. Adult worms and developing L4 stages disrupt the abomasal mucosa, causing hyperplasia of mucous neck cells, loss of parietal cells, and replacement of chief cells with undifferentiated epithelial cells [13, 15]. This metaplasia elevates abomasal pH from approximately 2.0 to 5.0-7.0, impairing pepsinogen activation and protein digestion. Concurrently, plasma pepsinogen concentrations rise due to leakage across the damaged mucosa, serving as a historical biomarker of infection intensity [15].

Excretory-secretory (ES) products released by parasitic stages modulate host immunity. Protein disulfide isomerase (PDI) and annexin-like proteins have been characterized as major ES components with potential roles in immune evasion and tissue penetration [3, 12]. O. ostertagi extracts suppress bovine T-lymphocyte proliferation and cytokine production, contributing to the relative immunosuppression observed in heavily infected animals [11]. These immunomodulatory properties complicate vaccine development and influence serological assay performance [8].

1.2 Clinical Syndromes

Two clinical forms are recognized. Type I ostertagiosis occurs in first-season grazing calves during summer and autumn following ingestion of large numbers of L3. Type II ostertagiosis manifests in late winter or spring when hypobiotic L4 resume development synchronously, causing severe diarrhea, weight loss, and mortality in older cattle [5, 7]. Subclinical infections in adult dairy cows reduce milk yield, milk fat, and protein percentages, representing the primary economic impact in temperate dairy systems [6, 9].

2. Coprological Diagnostics and Fecal Egg Count Reduction Test

2.1 Quantitative Fecal Egg Counting

The modified McMaster technique remains the reference method for quantifying nematode eggs per gram (EPG) of feces. Sensitivity is typically 50 EPG with a 2 g fecal sample and saturated sodium chloride flotation solution (specific gravity 1.20). Alternative flotation media include zinc sulfate (specific gravity 1.18) and commercial automated systems utilizing image analysis algorithms. Trichostrongylid eggs (including Ostertagia, Haemonchus, Trichostrongylus, Cooperia) are morphologically indistinguishable; therefore, larval culture and differentiation (L3 morphology) or molecular speciation (ITS-2 rDNA sequencing) are required for genus-level diagnosis [1, 13].

2.2 Fecal Egg Count Reduction Test (FECRT) Protocol

The FECRT is the in vivo gold standard for detecting anthelmintic resistance. The World Association for the Advancement of Veterinary Parasitology (WAAVP) guidelines specify:

1. Animal selection: Minimum 15 animals per treatment group, naturally infected, with pre-treatment EPG ≥ 150.
2. Treatment: Accurate dosing based on individual body weight using calibrated dosing equipment.
3. Sampling: Paired fecal samples collected at day 0 (pre-treatment) and day 14 (post-treatment for macrocyclic lactones; day 10-14 for benzimidazoles and levamisole).
4. Calculation: Percentage reduction = (1 - (mean post-treatment EPG / mean pre-treatment EPG)) × 100. Arithmetic or geometric means may be used; bootstrap confidence intervals (95%) are recommended for statistical inference.

Table 1: FECRT Interpretation Criteria for Cattle Nematodes

Thresholds adapted from WAAVP second edition guidelines. Lower thresholds for ML reflect higher intrinsic efficacy.

2.3 Limitations and Statistical Considerations

FECRT sensitivity is influenced by pre-treatment egg count distribution, sample size, and aggregation parameter (k) of the negative binomial distribution. Low pre-treatment counts (< 150 EPG) reduce statistical power. Composite sampling (pooling feces from 10-15 animals) reduces cost but obscures individual variation and precludes confidence interval estimation. Bayesian hierarchical models incorporating prior resistance prevalence improve inference in low-count scenarios [2].

3. Immunodiagnostics: ELISA for Anti-Ostertagia Antibodies

3.1 Antigen Preparation and Assay Formats

Commercial and in-house ELISAs utilize crude adult worm somatic extracts, L3/L4 ES antigens, or recombinant proteins (e.g., PDI, annexins, activation-associated secreted proteins ASPs) [3, 12]. The indirect ELISA format detects IgG1 and IgG2 isotypes in serum, plasma, or milk. Bulk tank milk (BTM) ELISA enables herd-level surveillance in dairy operations without individual animal handling [6, 9].

Optical density (OD) ratio calculation: OD ratio = (Sample OD - Negative control OD) / (Positive control OD - Negative control OD)

3.2 Bulk Milk ELISA Epidemiology

BTM antibody levels correlate with herd exposure intensity and production losses. Optical density ratio (ODR) thresholds categorize herds into exposure categories:

Table 2: Bulk Milk ELISA ODR Interpretation for Dairy Herds

Thresholds derived from longitudinal studies in Northwestern Europe [6, 9].

Serum ELISA in youngstock provides age-specific exposure profiles. First-season grazers typically seroconvert 3-5 weeks post-turnout. Peak ODR coincides with patent infection; declining ODR reflects acquired immunity. Paired serum samples (pre- and post-grazing season) quantify cumulative exposure [9].

3.3 Assay Performance Characteristics

Sensitivity and specificity vary with antigen preparation and host factors. Crude extract ELISAs show cross-reactivity with Cooperia oncophora and Haemonchus placei antibodies. Recombinant antigen cocktails improve specificity. Milk IgG1 correlates strongly with serum IgG1 (r > 0.85). Milk fat content and stage of lactation introduce variability; standardization to fat-corrected milk or use of milk whey improves reproducibility [6].

4. Abattoir Surveillance and Lesion Scoring

Post-mortem examination of the abomasum provides direct evidence of infection intensity and pathology. The standardized lesion scoring system enumerates raised nodules (0.5-3 mm diameter) on the mucosal surface [4, 7].

Table 3: Abomasal Lesion Scoring System

Lesion scores correlate with worm burden (r = 0.6-0.8), plasma pepsinogen, and prior grazing history. Abattoir data enable retrospective herd health monitoring and validation of ante-mortem diagnostics [4, 7].

5. Molecular Diagnostics and Resistance Genotyping

5.1 Species Identification

Conventional PCR and quantitative PCR (qPCR) targeting the internal transcribed spacer 2 (ITS-2) region of ribosomal DNA differentiate O. ostertagi from other trichostrongylids in fecal samples. Multiplex assays simultaneously detect Cooperia, Haemonchus, Trichostrongylus, and Nematodirus. Sensitivity reaches 1 egg per reaction; quantification correlates with McMaster EPG (R² > 0.9) [1].

5.2 Resistance Allele Detection

Benzimidazole resistance is associated with single nucleotide polymorphisms (SNPs) in the β-tubulin isotype 1 gene at codons 167 (Phe→Tyr), 198 (Glu→Ala), and 200 (Phe→Tyr). Pyrosequencing, allele-specific qPCR, and next-generation amplicon sequencing quantify resistance allele frequencies in pooled L3 larvae. Macrocyclic lactone resistance mechanisms involve P-glycoprotein efflux pumps (pgp genes) and glutamate-gated chloride channel mutations; validated molecular markers for field use in O. ostertagi remain under development [2, 8].

6. Anthelmintic Resistance Monitoring Frameworks

6.1 Integrated Surveillance Design

Effective resistance monitoring combines:

1. Annual FECRT on sentinel farms representing regional production systems.
2. BTM ELISA trend analysis to detect declining treatment efficacy (rising ODR despite treatment).
3. Molecular screening of pooled larvae for BZ resistance alleles.
4. Abattoir lesion scoring of cull cows to assess cumulative exposure.

6.2 Decision Thresholds for Treatment Modification

Table 4: Resistance Monitoring Decision Matrix

Combination therapy refers to concurrent administration of two or more anthelmintic classes with distinct modes of action.

6.3 Computational Modeling of Resistance Spread

Population genetics models (e.g., individual-based stochastic simulations) incorporate parameters: initial resistance allele frequency, dominance coefficient, fitness cost, refugia proportion, treatment frequency, and pasture contamination dynamics. These models predict time to clinical resistance failure and optimize refugia-based strategies. Integration with geographic information systems (GIS) enables regional risk mapping [8].

7. Targeted Selective Treatment (TST) Strategies

7.1 Principles and Indicators

TST restricts anthelmintic administration to animals exceeding defined thresholds, preserving susceptible parasite populations in refugia. Selection criteria for cattle include:

• Weight gain performance: Daily live weight gain (DLWG) below cohort median or predefined threshold (e.g., < 0.7 kg/day for growing cattle).
• Fecal egg count: Individual EPG > 200 (first-season grazers) or > 50 (second-season grazers).
• Serum pepsinogen: > 1000 mU tyrosine (type I) or > 3000 mU tyrosine (type II risk).
• Milk yield deviation: > 10% below predicted lactation curve (dairy cows).
• Body condition score (BCS): Loss > 0.5 points over 4 weeks.

7.2 TST Implementation Workflow

flowchart TD
    A[Herd Enrollment], > B{Baseline Diagnostics}
    B, > C[BTM ELISA ODR]
    B, > D[Composite FEC]
    B, > E[Abattoir Lesion Data]
    C, > F[Exposure Category Assignment]
    D, > F
    E, > F
    F, > G{High Exposure?}
    G, >|Yes| H[Strategic Whole-Herd Treatment]
    G, >|No| I[TST Protocol Activation]
    I, > J[Individual Animal Assessment]
    J, > K{Meets Treatment Criteria?}
    K, >|Yes| L[Targeted Anthelmintic Administration]
    K, >|No| M[No Treatment; Refugia Maintenance]
    L, > N[Post-Treatment Monitoring]
    M, > N
    N, > O[FECRT at 14 Days]
    O, > P{Efficacy > Threshold?}
    P, >|Yes| Q[Continue TST; Annual Review]
    P, >|No| R[Resistance Investigation; Class Rotation]
    R, > Q
    Q, > S[Next Grazing Season]
    S, > B

7.3 Economic and Epidemiological Outcomes

Modeling studies demonstrate TST reduces anthelmintic usage by 30-60% compared to blanket treatment while maintaining equivalent production outputs. Refugia preservation delays resistance selection. Critical success factors include accurate weighing equipment, regular performance recording, and veterinary oversight. Integration with precision livestock farming technologies (automatic weighing, activity monitors) enhances feasibility [2, 8].

8. Alternative and Adjunctive Control Measures

8.1 Biological Control

The nematophagous fungus Duddingtonia flagrans (strain CG 722) reduces pasture L3 availability when fed to cattle as chlamydospore boluses. Efficacy varies with stocking rate and climatic conditions; integration with TST reduces overall anthelmintic dependence [14].

8.2 Phytochemical and Nutraceutical Approaches

Plant secondary metabolites (condensed tannins, saponins, alkaloids) exhibit in vitro anthelmintic activity against O. ostertagi L3 and adults. In vivo efficacy is inconsistent due to variable bioavailability, palatability, and potential toxicity. Standardized extracts require rigorous pharmacokinetic and residue depletion studies before regulatory approval [1].

8.3 Vaccination Prospects

Recombinant vaccines targeting ES proteins (PDI, annexins, ASPs) have shown partial protection (30-60% worm burden reduction) in experimental challenges. Prime-boost regimens with adjuvant optimization are under investigation. Commercial vaccines remain unavailable; immune correlates of protection are not fully defined [8, 12].

9. Diagnostic Algorithm for Clinical Practice

9.1 First-Season Grazing Calves (Type I Risk)

1. Turnout: Baseline composite FEC; BTM ELISA (dairy herds).
2. Mid-season (8-10 weeks): Individual FEC on 10-15 calves; weigh all calves.
3. Decision: Treat if mean FEC > 200 EPG or > 20% calves below DLWG threshold.
4. Post-treatment: FECRT on treated group at day 14.
5. Housing: Serum pepsinogen on 10 calves to assess subclinical damage.

9.2 Adult Dairy Cows (Subclinical/Type II Risk)

1. Dry period: BTM ELISA monthly; individual serum ELISA on high-yielding cows.
2. Early lactation: Milk yield monitoring; treat cows with > 15% yield depression and ODR > 0.5.
3. Annual: FECRT on periparturient cows if treatment administered.
4. Cull cows: Request abattoir lesion scores.

9.3 Beef Suckler Herds

1. Pre-weaning: Composite FEC on calves; cow BCS assessment.
2. Post-weaning: Individual calf FEC and weight; TST based on DLWG.
3. Housing: Pepsinogen on purchased replacements.
4. Turnout: Strategic treatment only if prior season FECRT indicated resistance.

10. Data Management and Digital Integration

Centralized databases linking diagnostic results (FEC, ELISA, FECRT, genotypes), treatment records, grazing management, and production data enable longitudinal herd health analysis. Application programming interfaces (APIs) connect laboratory information management systems (LIMS) with farm management software. Machine learning algorithms trained on multi-herd datasets predict resistance emergence risk and optimize TST thresholds for specific farm contexts [8].

11. Conclusion

Sustainable control of ostertagiosis requires a paradigm shift from calendar-based blanket treatment to evidence-based, diagnostics-driven targeted selective treatment. The fecal egg count reduction test remains the cornerstone of resistance detection, complemented by bulk milk ELISA for herd-level exposure monitoring and molecular genotyping for early resistance allele surveillance. Integration of these tools within a structured monitoring framework, supported by computational modeling and digital data pipelines, preserves anthelmintic efficacy while maintaining cattle productivity. Continued research into vaccine candidates, biological control agents, and standardized phytochemical formulations will expand the non-chemical armamentarium. Veterinary practitioners must champion diagnostic-led approaches to mitigate the escalating threat of multi-class anthelmintic resistance in Ostertagia ostertagi.

References

[1] Hayat H, Abbas S, Zaman MA et al. Phytochemicals as inhibitors of pathogenesis to combat ostertagiosis, toxocariasis, trichostrongylosis and trichuriasis in cattle: A systematic review. Microb Pathog. 2026. https://pubmed.ncbi.nlm.nih.gov/41747782/

[2] Treatment failures lead to multiple deaths from ostertagiosis in dairy youngstock. Vet Rec. 2019. https://pubmed.ncbi.nlm.nih.gov/30655400/

[3] Sharma P, Jenkins M, Zarlenga D et al. Characterization of Ostertagia ostertagi annexin-like proteins at different developmental stages. Parasitol Res. 2017. https://pubmed.ncbi.nlm.nih.gov/28378195/

[4] Mendes J, Pinto C, Bernardo S et al. Prevalence of Ostertagia ostertagi lesions in slaughtered dairy cattle from São Miguel Island, Azores, Portugal. Vet Parasitol Reg Stud Reports. 2016. https://pubmed.ncbi.nlm.nih.gov/31014502/

[5] Ostertagiosis causes illthrift and death in older cattle. Vet Rec. 2013. https://pubmed.ncbi.nlm.nih.gov/24097882/

[6] Sekiya M, Zintl A, Doherty ML. Bulk milk ELISA and the diagnosis of parasite infections in dairy herds: a review. Ir Vet J. 2013. https://pubmed.ncbi.nlm.nih.gov/23883526/

[7] Larraillet L, Forbes AB, Pravieux JJ. Abattoir survey of abomasal lesions associated with ostertagiosis in adult cattle. Vet Rec. 2012. https://pubmed.ncbi.nlm.nih.gov/22872127/

[8] Rinaldi M, Geldhof P. Immunologically based control strategies for ostertagiosis in cattle: where do we stand? Parasite Immunol. 2012. https://pubmed.ncbi.nlm.nih.gov/21722144/

[9] Płoneczka-Janeczko K, Piekarska J, Rypuła K et al. A survey of anti-Ostertagia ostertagii antibody levels in bulk tank milk samples (BTM) in dairy herds in Lower Silesia Region (Poland). Pol J Vet Sci. 2011. https://pubmed.ncbi.nlm.nih.gov/21528723/

[10] Increase in the prevalence of Johne's disease in sheep in Scotland. Vet Rec. 2011. https://pubmed.ncbi.nlm.nih.gov/21257530/

[11] Gómez-Muñoz MT, Canals-Caballero A, Almeria S et al. Inhibition of bovine T lymphocyte responses by extracts of the stomach worm Ostertagia ostertagi. Vet Parasitol. 2004. https://pubmed.ncbi.nlm.nih.gov/15041095/

[12] Geldhof P, Vercauteren I, Knox D et al. Protein disulphide isomerase of Ostertagia ostertagi: an excretory-secretory product of L4 and adult worms? Int J Parasitol. 2003. https://pubmed.ncbi.nlm.nih.gov/12633650/

[13] Knox DP. The pathogenesis of ostertagiosis-worm or host-mediated changes? Vet J. 2000. https://pubmed.ncbi.nlm.nih.gov/10775465/

[14] Fernández AS, Larsen M, Henningsen E et al. Effect of Duddingtonia flagrans against Ostertagia ostertagi in cattle grazing at different stocking rates. Parasitology. 1999. https://pubmed.ncbi.nlm.nih.gov/10446709/

[15] Fox MT. Pathophysiology of infection with gastrointestinal nematodes in domestic ruminants: recent developments. Vet Parasitol. 1997. https://pubmed.ncbi.nlm.nih.gov/9460203/